Hepatocellular carcinoma: Trends of incidence and survival in Europe and the United States at the end of the 20th century

American Journal of Gastroenterology

Volumn 102, Issue 8, 2007, Pages 1661-1670

  Capocaccia, Riccardo ^a   Sant, Milena ^b   Berrino, Franco ^b   Simonetti, Arianna ^a   Santi, Valentina ^c   Trevisani, Franco ^c   Oberaigner, W ^d   Jechova, M ^e   Rousarova, M ^e   Storm, H H ^f   Aareleid, T ^g   Hakulinen, T ^h   Hedelin G ⁱ   Tron, I ^j   Le Gall, E ^j   Launoy, G ^k   Mace Lesech J ^l   Faivre, J ^m   Chaplain, G ⁿ   Carli, P M ^o   Danzon, A ^p   Tretarre, B ^q   Colonna, M ^r   Lacour, B ^s   Raverdy, N ^t   Berger, C ^u   Freycon, F ^u   Grosclaude, P ^v   Esteve J ^w   Kaatsch, P ^x   Ziegler, H ^y   Holzel D ^z   Schubert Fritschle, G ^z   Tryggvadottir, L ^aa   Allemani, C ^b   Baili, P ^b   Ciccolallo, L ^b   Gatta, G ^b   Micheli, A ^b   Taussig, E ^b   Carrani, E ^a   De Angelis, R ^a   Hartley, S ^a   Roazzi, P ^a   Santaquilani, M ^a   Tavilla, A ^a   Valente, F ^a   Verdecchia, A ^a   Ferretti, S ^ab   Crosignani, P ^b   Contiero, P ^b   Ramazzotti, V ^ac   Vercelli, M ^ad   Quaglia, A ^ad   Pannelli, F ^ae,af   Vitarelli, S ^ae   Mosciatti, P ^af   Federico, M ^ag   Artioli, M E ^ag   Ponz De Leon, M ^ah   Benatti, P ^ah   De Lisi, V ^ai   Serventi, L ^ai   Zanetti, R ^aj   Patriarca, S ^aj   Magnani, C ^ak   Pastore, G ^ak   Gafa L ^al   Tumino, R ^al   Falcini, F ^am   Budroni, M ^an   Paci, E ^ao   Crocetti, E ^ao   Zambon, P ^ap   Guzzinati, S ^ap   Dalmas, M ^aq   Langmark, F ^ar   Andersen, A ^ar   Rachtan, J ^as   Bielska Lasota, M ^at   Wronkowski, Z ^at   Zwierko, M ^at   Pinheiro, P S ^au   Pleko, I ^av   Obsitnikova A ^av   Pompe Kirn, V ^aw   Izarzugaza, I ^ax   Martinez Garcia, C ^ay   Garau, I ^az   Navarro, C ^ba   Chirlaque, M D ^ba   Ardanaz, E ^bb   Moreno, C ^bb   Galceran, J ^bc   Torrella, A ^bd   Peris Bonet, R ^be   Barlow, L ^bf   Moller T ^bf   Jundt, G ^bg   Lutz, J M ^bh   Usel, M ^bh   Coebergh, J W W ^bi   Van Der Does Van Den Berg, A ^bj   Visser, O ^bk   Godward, S ^bl   Coleman, M P ^bm   Williams, E M I ^bn   Forman, D ^bo   Quinn, M J ^bp   Roche, M ^bq   Edwards, S ^bq   Stiller, S ^br   Verne, J ^bs   Moller H ^bt   Bell, J ^bt   Botha, J L ^bu   Lawrence, G ^bv   Black, R ^bw   Brewster, D ^bw   Steward, J A ^bx   more..

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Tyrol Cancer Registry   (Austria)

^e Institute of Health Information and Statistics of the Czech Republic   (Czech Republic)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g Estonian Cancer Registry   (Estonia)

^h FINNISH CANCER REGISTRY   (Finland)

ⁱ Cancer Registry of Bas Rhin   (France)

^j Bretagne Childhood Cancer Registry   (France)

^k Calvados Digestive Cancer Registry   (France)

^l Calvados General Cancer Registry   (France)

^m ote d'Or Digestive Cancer Registry   (France)

ⁿ Côte d'Or Gynaecological Cancer Registry   (France)

^o ote d'Or Malignant Haemopathies Registry   (France)

^p Doubs Cancer Registry   (France)

^q Herault Cancer Registry   (France)

^r Is ere Cancer Registry   (France)

^s Lorraine Childhood Cancer Registry   (France)

^t Somme Cancer Registry   (France)

^u Rhone Alpes Childhood Registry   (France)

^v Tarn Cancer Registry   (France)

^w UNIVERSITÉ LYON 1   (France)

^x German Childhood Cancer Registry   (Germany)

^y Saarland Cancer Registry   (Germany)

^z Munich Cancer Registry   (Germany)

^aa ICELANDIC CANCER REGISTRY   (Iceland)

^ab Ferrara Cancer Registry   (Italy)

^ac Latina Cancer Registry   (Italy)

^ad UNIVERSITY OF GENOA   (Italy)

^ae Macerata Cancer Registry   (Italy)

^af Marche Childhood Cancer Registry   (Italy)

^ag MODENA CANCER REGISTRY   (Italy)

^ah Marche Childhood Cancer Registry ^*  (Italy)

^ai PARMA CANCER REGISTRY   (Italy)

^aj CPO Centre for Epidemiology and Prevention in Oncology in Piedmont   (Italy)

^ak Piedmont Childhood Cancer Registry   (Italy)

^al Ragusa Cancer Registry   (Italy)

^am Romagna Cancer Registry   (Italy)

^an Sassari Cancer Registry   (Italy)

^ao Tuscan Cancer Registry   (Italy)

^ap Venetian Cancer Registry   (Italy)

^aq Malta National Cancer Registry   (Malta)

^ar CANCER REGISTRY OF NORWAY   (Norway)

^as Cracow Cancer Registry   (Poland)

^at INSTITUTE OF ONCOLOGY   (Poland)

^au Southern Portugal Cancer Registry   (Portugal)

^av National Cancer Registry of   (Slovakia)

^aw INSTITUTE OF ONCOLOGY   (Slovenia)

^ax Basque Country Cancer Registry   (Spain)

^ay Granada Cancer Registry   (Spain)

^az Mallorca Cancer Registry   (Spain)

^ba Murcia Cancer Registry   (Spain)

^bb Navarra Cancer Registry   (Spain)

^bc Tarragona Cancer Registry   (Spain)

^bd Childhood Tumour Registry of Valencia   (Spain)

^be National Registry of Childhood Tumours   (Spain)

^bf Cancer Registry of Sweden   (Sweden)

^bg Cancer Registry of Basel   (Switzerland)

^bh GENEVA CANCER REGISTRY   (Switzerland)

^bi Eindhoven Cancer Registry   (Netherlands)

^bj Dutch Childhood Oncology Group   (Netherlands)

^bk Cancer Center Amsterdam   (Netherlands)

^bl East Anglian Cancer Registry   (United Kingdom)

^bm LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^bn Merseyside and Cheshire Cancer Registry   (United Kingdom)

^bo Northern and Yorkshire Cancer Registry and Information Service   (United Kingdom)

^bp OFFICE FOR NATIONAL STATISTICS   (United Kingdom)

^bq UNIVERSITY OF OXFORD   (United Kingdom)

^br Childhood Cancer Research Group   (United Kingdom)

^bs Oxford Cancer Intelligence Unit ^*  (United Kingdom)

^bt Thames Cancer Registry   (United Kingdom)

^bu Trent Cancer Registry   (United Kingdom)

^bv W Midlands Cancer Intelligence Unit   (United Kingdom)

^bw Cancer Information Group   (United Kingdom)

^bx Welsh Cancer Intelligence and Surveillance Unit   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; UNITED STATES;

EID: 34547636501     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01337.x     Document Type: Article

References (42)

1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001 94 : 153 6.
2. Yu MC, Yuan J-M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004 127 : S72 8.
3. Bosch FX, Ribes J, Dìaz M, et al. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004 127 : S5 16.
4. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001 33 : 62 5.
5. Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 2004 127 : S35 50.
6. Sherman M. Hepatocellular carcinoma: Epidemiology, risk factors, and screening. Semin Liver Dis 2005 24 : 143 54.
7. Kerr D, Bevan H, Gowland B, et al. Redesigning cancer care. BMJ 2002 324 : 164 6.
8. National Board of Health. National Cancer Plan, Report 2 - Epidemiology. Copenhagen : National Board of Health, 2000.
9. Norges Offentlige Utredninger. Care and knowledge: The Norwegian cancer plan 1997 [Omsorg og Kunnskap® Norsk kreftplan 1997]. Oslo, Statens Trykning : 1997.
10. Berrino F, Sant M, Verdecchia A, et al. Survival of cancer patients in Europe: The EUROCARE study. IARC Scientific Publications No. 132. Lyon : IARC Press, 1995.
11. Berrino F, Capocaccia R, Estève J, et al. Survival of cancer patients in Europe: The EUROCARE-2 study. IARC Scientific Publications No. 151. Lyon : IARC Press, 1999.
12. Berrino F, Capocaccia R, Coleman MP, et al. Survival of Cancer Patients in Europe: The EUROCARE-3 Study. Ann Oncol 2003 14 (Suppl 5) : v1 155
13. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2004, Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005 based on the November 2004 submission.
14. Trevisani F, D'Intino PE, Grazi GL, et al. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Cancer 1996 77 : 2223 32.
15. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003 362 : 1907 17.
16. Manual of the international statistical classification of diseases, injuries, and causes of death. International Classification of Diseases for Oncology. Geneva : WHO, 1977.
17. Percy C, VanHolten V, Muir C. The International classification of diseases for oncology, 2nd Ed. Geneva : WHO, 1990.
18. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982 38 : 933 42.
19. Micheli A, Baili P, Quinn M, et al. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol 2003 14 (Suppl 5) : v28 40.
20. Greenwood M. The natural duration of cancer. Report on Public Health and Medical Subjects N° 33. London : His Majesty's Stationery Office, 1926.
21. Gatta G, Capocaccia R, Coleman MP, et al. Toward a comparison of survival in American and European cancer patients. Cancer 2000 89 : 893 900.
22. Gores JG. Cholangiocarcinoma: Current concepts and insights. Hepatology 2003 5 : 961 9.
23. Tiribelli C, Bellentani S, Campello C. The north-to-south gradient of hepatitis C virus infection. Scand J Gastroenterol 2003 38 : 805 6.
24. Taylor-Robinson SD, Foster GR, Arora S, et al. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997 350 : 1142 3.
25. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999 340 : 745 50.
26. McGlynn KA, Tsao L, Hsing AW, et al. International trends and patterns of primary liver cancer. Int J Cancer 2001 94 : 290 6.
27. Khan SA, Taylor-Robinson SD, Toledano MB, et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002 37 : 806 13.
28. Benhamiche AM, Faivre C, Minello A, et al. Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995. J Hepatol 1998 29 : 802 6.
29. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: An analysis of routine data. Lancet 2006 367 : 52 6.
30. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004 127 : S87 96.
31. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004 126 : 460 8.
32. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents Vol. VIII. IARC Scientific Publications No. 155. Lyon : IARC Press, 2005.
33. El-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004 127 : S27 34.
34. Simonetti RG, Cammà C, Fiorello F, et al. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991 36 : 962 72.
35. Trevisani F, D'Intino PE, Caraceni P, et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 1995 75 : 2220 32.
36. Tanaka K, Sakai H, Hashizume M, et al. Serum testosterone: Estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Res 2000 60 : 5106 10.
37. El-Serag HB, Siegel AB, Davila JA, et al. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study. J Hepatol 2006 44 : 158 66.
38. Adams PC, Arthur MJ, Boyer TD, et al. Screening in liver disease: Report of an AASLD clinical workshop. Hepatology 2004 39 : 1204 12.
39. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005 42 : 1208 35.
40. Yuen MF, Cheng CC, Lauder IJ, et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000 31 : 330 5.
41. Trevisani F, Cantarini MC, Labate AM, et al. Italian Liver Cancer (ITALICA) group. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: Effects on cancer staging and patient survival. Am J Gastroenterol 2004 99 : 1470 6.
42. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004 130 : 417 22.